ID
41514
Descripción
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma
Palabras clave
Versiones (2)
- 18/9/20 18/9/20 -
- 30/10/20 30/10/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
30 de octubre de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162
Yearly Follow-up contact; Anti Cancer Therapy (Report Final and Annex Report 2 Final)
Descripción
Yearly Follow-up - Check for Follow-up contact
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C0332158
Descripción
Yes → Date of contact No → Please complete the Death Form. Please complete the Study Conclusion Unknown → Please specify the reason
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2584946
Descripción
If patient ist alive, enter date of contact
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2584946
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C1705415
Descripción
If unknown if patient is still alive, please specify reason
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2584946
- UMLS CUI [2]
- C0439673
- UMLS CUI [3,1]
- C0392360
- UMLS CUI [3,2]
- C2348235
Descripción
If other reason, please specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3840932
- UMLS CUI [1,2]
- C2348235
Descripción
End of yearly Follow-up contact
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C0332158
- UMLS CUI-3
- C0444930
Descripción
Anti-cancer therapy(ies) following last study treatment administration
Alias
- UMLS CUI-1
- C0920425
- UMLS CUI-2
- C3469597
- UMLS CUI-3
- C0304229
- UMLS CUI-4
- C1517741
Descripción
Subsequent treatment
Alias
- UMLS CUI-1
- C0087111
- UMLS CUI-2
- C0332282
Descripción
Type of therapy
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0332307
- UMLS CUI [1,2]
- C0087111
Descripción
Specify
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348235
Descripción
Date of First Treatment administration/ surgery
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0205435
- UMLS CUI [1,4]
- C0011008
- UMLS CUI [2,1]
- C0543467
- UMLS CUI [2,2]
- C0205435
- UMLS CUI [2,3]
- C0011008
Descripción
Date of last Treatment administration (Not applicable for surgery)
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C1517741
- UMLS CUI [1,4]
- C0011008
Similar models
Yearly Follow-up contact; Anti Cancer Therapy (Report Final and Annex Report 2 Final)
C0332158 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C1705415 (UMLS CUI [1,3])
C0439673 (UMLS CUI [2])
C0392360 (UMLS CUI [3,1])
C2348235 (UMLS CUI [3,2])
C2348235 (UMLS CUI [1,2])
C0332158 (UMLS CUI-2)
C0444930 (UMLS CUI-3)
C1517741 (UMLS CUI [1,2])
C0332158 (UMLS CUI [1,3])
C3469597 (UMLS CUI-2)
C0304229 (UMLS CUI-3)
C1517741 (UMLS CUI-4)
C3469597 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C1517741 (UMLS CUI [3])
C0304229 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0543467 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C0011008 (UMLS CUI [2,3])
C0304229 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])